COVID-19 Vaccine R&D and Manufacturing in the US and in India - Part 2

This time on Research Radio we have with us Prof. Sunil Mani for a two-part episode on COVID-19 vaccine R&D and manufacturing in the US and in India based on his Special Article titled "The Role of Industrial Policy in Market-friendly Economies: Case of COVID-19 Vaccine R&D and Its Manufacturing in India and the US—I" and "The Role of Industrial Policy in Market-friendly Economies: Case of COVID-19 Vaccine R&D and Its Manufacturing in India and Its Contrast with the US—II". Prof. Mani is director and professor, RBI Chair, at the Centre for Development Studies, Thiruvananthapuram.
In Part 1 of this episode we will look at the differences in the approach adopted by the US and by India and the role of the each respective government in promoting R&D and Manufacturing.  
In Part 2 of this episode we discuss how intellectual property laws can facilitate and hinder the development and production of vaccines and the delicate balance of public private partnerships needed especially in the field of knowledge production and healthcare.
For more episodes and to listen to EPW's other podcast Research Radio head to https://www.epw.in/podcasts
Subscribe to EPW to access all our content including the archives of The Economic and Political Weekly and The Economic Weekly dating back to 1949. https://www.epw.in/subscribe.html